Left Bundle Branch Block-associated Cardiomyopathy: A New Approach
Shunmuga Sundaram Ponnusamy1, Pugazhendhi Vijayaraman2, Kenneth A Ellenbogen3
1Department of Cardiology, Velammal Medical College Madurai, India.
Insights
Left bundle branch block (LBBB) often indicates heart disease. For LBBB-associated cardiomyopathy, conduction system pacing, like left bundle branch pacing, shows promise for reversing heart remodeling and improving outcomes.
Area of Science:
- Cardiology
- Electrophysiology
- Heart Failure
Background:
- Left bundle branch block (LBBB) is linked to structural heart disease, increased morbidity, and mortality.
- Current guidelines suggest cardiac resynchronisation therapy (CRT) for cardiomyopathy with LBBB after 3 months of medical therapy.
- Medical therapy alone may be less effective, with most patients eventually requiring CRT.
Purpose of the Study:
- To review the mechanisms, evidence, and role of conduction system pacing in LBBB-associated cardiomyopathy.
- To highlight LBBB-associated cardiomyopathy as a potentially reversible condition.
- To discuss left bundle branch pacing as a CRT strategy.
Main Methods:
- Review of published literature on LBBB-associated cardiomyopathy and conduction system pacing.
- Analysis of clinical trial data regarding CRT efficacy in LBBB patients.
- Examination of reverse remodeling outcomes following left bundle branch pacing.
Main Results:
- CRT has demonstrated favorable clinical outcomes in patients with LBBB.
- Left bundle branch pacing can lead to significant reverse remodeling in LBBB-associated cardiomyopathy.
- Conduction system pacing offers a potential alternative CRT approach.
Conclusions:
- LBBB-associated cardiomyopathy may be reversible with appropriate pacing.
- Left bundle branch pacing is an effective strategy for CRT in selected patients.
- Conduction system pacing represents a valuable tool in managing heart failure with LBBB.
Abstract:
Left bundle branch block (LBBB) is frequently associated with structural heart disease, and predicts higher rates of morbidity and mortality. In patients with cardiomyopathy (ejection fraction <35%) and LBBB, current guidelines recommend cardiac resynchronisation therapy (CRT) after 3 months of medical therapy. However, studies have suggested that medical therapy alone would be less effective, and the majority of patients would still need CRT at the end of 3 months. Conversely, CRT trials have shown better results and favourable clinical outcomes in patients with LBBB. In the absence of any other known aetiology, LBBB-associated cardiomyopathy represents a potentially reversible form of cardiomyopathy, with the majority of the patients having reverse remodelling after CRT by left bundle branch pacing. This review provides the mechanism, published evidence and role of conduction system pacing for patients with LBBB-associated cardiomyopathy.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Coronary Artery Disease IV: Medical Management


